1-4 of 4
Alastair M. Gray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data

Jose Leal, Shelby D. Reed, Rishi Patel, Oliver Rivero-Arias, Yanhong Li, Kevin A. Schulman, Robert M. Califf, Rury R. Holman, Alastair M. Gray
Journal: Diabetes Care
Diabetes Care 2020;43(10):2485–2492
https://doi.org/10.2337/dc20-0717
Published: 12 August 2020
View article titled, Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data
Open the PDF for Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data in another window
Journal Articles

Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

Shelby D. Reed, Yanhong Li, Helen A. Dakin, Frauke Becker, Jose Leal, Stephanie M. Gustavson, Bernt Kartman, Eric Wittbrodt, Robert J. Mentz, Neha J. Pagidipati, M. Angelyn Bethel, Alastair M. Gray, Rury R. Holman, Adrian F. Hernandez
Journal: Diabetes Care
Diabetes Care 2020;43(2):374–381
https://doi.org/10.2337/dc19-0950
Published: 05 December 2019
View article titled, Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Open the PDF for Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) in another window
Includes: Supplementary data
Journal Articles

Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data

John M. Dennis, William E. Henley, Michael N. Weedon, Mike Lonergan, Lauren R. Rodgers, Angus G. Jones, William T. Hamilton, Naveed Sattar, Salim Janmohamed, Rury R. Holman, Ewan R. Pearson, Beverley M. Shields, Andrew T. Hattersley, MASTERMIND Consortium, Catherine Angwin, Kennedy J. Cruickshank, Andrew J. Farmer, Stephen C.L. Gough, Alastair M. Gray, Christopher Hyde, Christopher Jennison, Mark Walker
Journal: Diabetes Care
Diabetes Care 2018;41(9):1844–1853
https://doi.org/10.2337/dc18-0344
Published: 02 August 2018
View article titled, Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
Open the PDF for Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data in another window
Includes: Supplementary data
Journal Articles

Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data

Jose Leal, DPHIL, Alison J. Hayes, PHD, Alastair M. Gray, PHD, Rury R. Holman, MB, CHB, FRCP, Philip M. Clarke, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(6):1541–1546
https://doi.org/10.2337/dc12-1120
Published: 15 May 2013
View article titled, Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data
Open the PDF for Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data in another window
Includes: Supplementary data